Amplitude Surgical : Impact COVID-19 de 4,2 M€ au T3 - Reprise totale estimée en juillet/aout
>CA T3 en baisse de 9,8% - Le CA T3 ressort à 26,6 M€ (vs 29,8 M€e), soit une baisse de 9,8% et de 8,6% à données comparables, avec un CA France en recul de 10,4% et un CA RoW diminuant de 8,6% (-5,1% à tcc), avec une baisse de 9,8% dans les filiales (-4,8% à tcc) et de 5,6% chez les distributeurs. La perte globale due la crise sanitaire s’élève à environ 4,2 M€e sur le mois de mars. L’activité directe d’Amplitude (ie. France+filiales), soit 90% des revenus du groupe,...Amplitude Surgical SA is a France-based company engaged in the field of orthopedic surgeries. The Company offers the AMPLIVISION system, a computer navigation workstation and its related software, which is fully developed by the Company in collaboration with surgeons. Each implant is validated mechanically by creating models and running tests on simulators. Amplitude Surgical SAS relies on the expertise of its design offices and on scientific partnerships to internally design and develop its implants and automatic or computer-navigated instruments. It operates through ofab Orthopedie, a strategic industrial subcontractor
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.